24/7 Patient Assistance: 760-405-8205

Carolyn Calfee, MD


Write a review
Doctor's profile photo

Request a call back

Conditions Treated Asbestosis Diffuse Pleural Thickening Ovarian Cancer Pleural Mesothelioma Pleural Plaques Pleuritis Rounded Atelectasis Testicular Mesothelioma

specialties & services

  • Bio & Insurance Information

    Dr. Carolyn Calfee is a specialist in pulmonology based in San Francisco, California. She works at several hospitals in the area, such as UCSF Medical Center and San Francisco General Hospital. She got her diploma from Perelman School of Medicine at the University of Pennsylvania and did her residency at UCSF and a chief residency program at the University of California at San Francisco. She did a fellowship in pulmonary disease and critical care medicine at UCSF. The doctor is board certified in pulmonary disease and critical care medicine and has an experience of more than 20 years.

    Insurance Accepted

    CignaFirst Health PPOMultiPlan

  • Education & Training


    Perelman at the University of Pennsylvania

    Medical School







  • Board Certifications

    American Board of Internal Medicine - Pulmonary Disease

  • Hospital & Practice

    San Francisco General Hospital

    Languages: English/Spanish

    (415) 206-8000

    1001 Potrero Ave

    San Francisco, California 94110

    Read More

    UCSF Medical Center

    Languages: English/Spanish

    (415) 353-1037

    505 Parnassus Ave

    San Francisco, California 94143

    Read More
  • Publications & Memberships

    Dr. Carolyn Calfee has contributed to 3 publications.

    Diagnostic workup for ARDS patients.

    Papazian, L.,Calfee, C. S.,Chiumello, D.,Luyt, C. E.,Meyer, N. J.,Sekiguchi, H.,Matthay, M. A.,Meduri, G. U.; Intensive Care Med. 1900 Jan 01.

    See more >>

    Plasma angiopoietin-2 outperforms other markers of endothelial injury in prognosticating pediatric ARDS mortality.

    Zinter, M. S.,Spicer, A.,Orwoll, B. O.,Alkhouli, M.,Dvorak, C. C.,Calfee, C. S.,Matthay, M. A.,Sapru, A.; Am. J. Physiol. Lung Cell Mol. Physiol.. 2015 Dec 15.

    See more >>

    Cigarette smokers have exaggerated alveolar barrier disruption in response to lipopolysaccharide inhalation.

    Moazed, F.,Burnham, E. L.,Vandivier, R. W.,O'Kane, C. M.,Shyamsundar, M.,Hamid, U.,Abbott, J.,Thickett, D. R.,Matthay, M. A.,McAuley, D. F.,Calfee, C. S.; Thorax. 2016 Feb 04.

    See more >>